Global Fragment-based Drug Discovery Market By Type (Fragment Screening, and Fragment Optimization), By Application (Biopharmaceutical Companies, CROs, and Academic and Research Institutions), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029
- 138819
- 18-Dec
- PDF/PPT/Word
-
Report Details
Global Fragment-based Drug Discovery Market is estimated to be valued US$ XX.X million in 2019. The report on Fragment-based Drug Discovery Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global fragment-based drug discovery market is segmented on the basis of Type, Application, and geography.
Europe market was valued at US$ XX.X million in 2018 and is projected to reach US$ XX.X million in 2029, and register a CAGR of X.X% during the forecast period, according to a new Market.us (Prudour Research) study.
Fragment-based Drug Discovery Market Scope:
By type, the market is segmented into Fragment Screening, and Fragment Optimization. By Application, the market is divided into Biopharmaceutical Companies, CROs, and Academic and Research Institutions.
Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Astex Pharmaceuticals, Alveus Pharmaceuticals, Beactica, Charles River Laboratories, Crown Bioscience, Emerald BioStructures, Evotec, Kinetic Discovery, Proteros Fragments, Sprint Bioscience, Structure Based Design, and Sygnature Discovery.Key Market Segments
Type
Fragment Screening
Fragment Optimization
Application
Biopharmaceutical Companies
CROs
Academic and Research Institutions
Key Market Players included in the report:
Astex Pharmaceuticals
Alveus Pharmaceuticals
Beactica
Charles River Laboratories
Crown Bioscience
Emerald BioStructures
Evotec
Kinetic Discovery
Proteros Fragments
Sprint Bioscience
Structure Based Design
Sygnature Discovery
Reasons to Get this Report:
In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Fragment-based Drug Discovery Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Fragment-based Drug Discovery Market; high-growth regions; and market drivers, restraints, and also market chances.
The analysis covers Fragment-based Drug Discovery Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Fragment-based Drug Discovery Market across sections such as also Application and representatives.
Additionally, the analysis also has a comprehensive review of the crucial players on the Fragment-based Drug Discovery Market together side their company profiles, SWOT analysis, latest advancements, and business plans.The analysis objectives of the report are:
To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
To know the Fragment-based Drug Discovery Market by pinpointing its many subsegments.
To profile the important players and analyze their growth plans.
To endeavor the amount and value of Fragment-based Drug Discovery sub-markets, depending on key regions (various vital states).
To analyze Fragment-based Drug Discovery Market concerning growth trends, prospects, and also their participation in the entire sector.
To examine and study the Fragment-based Drug Discovery Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
Primary worldwide Fragment-based Drug Discovery Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market. -
Table Of Content
1. Fragment-based Drug Discovery Market Introduction
1.1. Definition
1.2. Taxonomy
1.3. Research Scope2. Executive Summary
2.1. Key Findings by Major Segments
2.2. Top strategies by Major Players3. Global Fragment-based Drug Discovery Market Overview
3.1. Fragment-based Drug Discovery Market Dynamics
3.1.1. Drivers
3.1.2. Opportunities
3.1.3. Restraints
3.1.4. Challenges3.2. PESTLE Analysis
3.3. Opportunity Map Analysis
3.4. PORTER’S Five Forces Analysis
3.5. Market Competition Scenario Analysis
3.6. Product Life Cycle Analysis
3.7. Opportunity Orbits
3.8. Production Analysis by Region/Company
3.9. Industry chain Analysis
3.10. Marketing Strategy4. Global Fragment-based Drug Discovery Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
4.1. Global Fragment-based Drug Discovery Market Analysis by Type: Introduction
4.2. Market Size and Forecast by Region
4.3. Fragment Screening4.4. Fragment Optimization
5. Global Fragment-based Drug Discovery Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
5.1. Global Fragment-based Drug Discovery Market Analysis by Application: Introduction
5.2. Market Size and Forecast by Region
5.3. Biopharmaceutical Companies5.4. CROs
5.5. Academic and Research Institutions
6. Global Fragment-based Drug Discovery Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
6.1. North America
6.1.1. North America Fragment-based Drug Discovery Market: Regional Trend Analysis
6.1.1.1. US
6.1.1.2. Canada
6.1.1.3. Mexico6.2.1. Europe
6.2.1. Europe Fragment-based Drug Discovery Market: Regional Trend Analysis
6.2.1.1. Germany
6.2.1.2. France
6.2.1.3. UK
6.2.1.4. Russia
6.2.1.5. Italy
6.2.1.6. Spain
6.2.1.7. Rest of Europe6.3. Asia-Pacific
6.3.1. Asia-Pacific Fragment-based Drug Discovery Market: Regional Trend Analysis
6.3.1.1. China
6.3.1.2. Japan
6.3.1.3. Korea
6.3.1.4. India
6.3.1.5. Rest of Asia-Pacific6.4. Latin America
6.4.1. Latin America Fragment-based Drug Discovery Market: Regional Trend Analysis
6.4.1.1. Brazil
6.4.1.2. Argentina
6.4.1.3. Rest of Latin America6.5. Middle East and Africa
6.5.1. Middle East and Africa Fragment-based Drug Discovery Market: Regional Trend Analysis
6.5.1.1. GCC
6.5.1.2. South Africa
6.5.1.3. Israel
6.5.1.4. Rest of MEA7. Global Fragment-based Drug Discovery Market Competitive Landscape, Market Share Analysis, and Company Profiles
7.1. Market Share Analysis
7.2. Company Profiles
7.3. Astex Pharmaceuticals7.3.1. Company Overview
7.3.2. Financial Highlights
7.3.3. Product Portfolio
7.3.4. SWOT Analysis
7.3.5. Key Strategies and Developments7.4. Alveus Pharmaceuticals
7.4.1. Company Overview
7.4.2. Financial Highlights
7.4.3. Product Portfolio
7.4.4. SWOT Analysis
7.4.5. Key Strategies and Developments7.5. Beactica
7.5.1. Company Overview
7.5.2. Financial Highlights
7.5.3. Product Portfolio
7.5.4. SWOT Analysis
7.5.5. Key Strategies and Developments7.6. Charles River Laboratories
7.6.1. Company Overview
7.6.2. Financial Highlights
7.6.3. Product Portfolio
7.6.4. SWOT Analysis
7.6.5. Key Strategies and Developments7.7. Crown Bioscience
7.7.1. Company Overview
7.7.2. Financial Highlights
7.7.3. Product Portfolio
7.7.4. SWOT Analysis
7.7.5. Key Strategies and Developments7.8. Emerald BioStructures
7.8.1. Company Overview
7.8.2. Financial Highlights
7.8.3. Product Portfolio
7.8.4. SWOT Analysis
7.8.5. Key Strategies and Developments7.9. Evotec
7.9.1. Company Overview
7.9.2. Financial Highlights
7.9.3. Product Portfolio
7.9.4. SWOT Analysis
7.9.5. Key Strategies and Developments7.10. Kinetic Discovery
7.10.1. Company Overview
7.10.2. Financial Highlights
7.10.3. Product Portfolio
7.10.4. SWOT Analysis
7.10.5. Key Strategies and Developments7.11. Proteros Fragments
7.11.1. Company Overview
7.11.2. Financial Highlights
7.11.3. Product Portfolio
7.11.4. SWOT Analysis
7.11.5. Key Strategies and Developments7.12. Sprint Bioscience
7.12.1. Company Overview
7.12.2. Financial Highlights
7.12.3. Product Portfolio
7.12.4. SWOT Analysis
7.12.5. Key Strategies and Developments7.13. Structure Based Design
7.13.1. Company Overview
7.13.2. Financial Highlights
7.13.3. Product Portfolio
7.13.4. SWOT Analysis
7.13.5. Key Strategies and Developments7.14. Sygnature Discovery
7.14.1. Company Overview
7.14.2. Financial Highlights
7.14.3. Product Portfolio
7.14.4. SWOT Analysis
7.14.5. Key Strategies and Developments8. Assumptions and Acronyms
9. Research Methodology
10. Contact -
Inquiry Before Buying
-
Request Sample
